Changes in neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio, and platelet to lymphocyte ratio during palliative radiotherapy may predict efficacy of immune checkpoint inhibitor as re-challenge treatment in advanced gastric cancer: a case report

HIGHLIGHTS

• who: Jianxin Chen et al. from the Fudan University, China have published the research work: Changes in Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio During Palliative Radiotherapy May Predict Efficacy of Immune Checkpoint Inhibitor as Re-Challenge Treatment in Advanced Gastric Cancer: A Case Report, in the Journal: (JOURNAL) of 10/02/2022
• what: Few studies were conducted to investigate the specific profiting population, with the mechanism of re-challenge remaining to be explored. Although the above clinical evidence reported a meaningful predictive value of NLR/ LMR/PLR in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.